These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 2555051

  • 1. Differentiation of human variant small cell lung cancer cell lines to a classic morphology by retinoic acid.
    Doyle LA, Giangiulo D, Hussain A, Park HJ, Yen RW, Borges M.
    Cancer Res; 1989 Dec 01; 49(23):6745-51. PubMed ID: 2555051
    [Abstract] [Full Text] [Related]

  • 2. Expression of p64c-myc and neuroendocrine properties define three subclasses of small cell lung cancer.
    Bepler G, Bading H, Heimann B, Kiefer P, Havemann K, Moelling K.
    Oncogene; 1989 Jan 01; 4(1):45-50. PubMed ID: 2536917
    [Abstract] [Full Text] [Related]

  • 3. Mechanism of all-trans-retinoic acid-mediated L-myc gene regulation in small cell lung cancer.
    Ou X, Campau S, Slusher R, Jasti RK, Mabry M, Kalemkerian GP.
    Oncogene; 1996 Nov 07; 13(9):1893-9. PubMed ID: 8934535
    [Abstract] [Full Text] [Related]

  • 4. Characterization of variant subclasses of cell lines derived from small cell lung cancer having distinctive biochemical, morphological, and growth properties.
    Gazdar AF, Carney DN, Nau MM, Minna JD.
    Cancer Res; 1985 Jun 07; 45(6):2924-30. PubMed ID: 2985258
    [Abstract] [Full Text] [Related]

  • 5. Additive and differential biological activity of alpha-interferon A, difluoromethylornithine, and their combination on established human lung cancer cell lines.
    Bepler G, Carney DN, Nau MM, Gazdar AF, Minna JD.
    Cancer Res; 1986 Jul 07; 46(7):3413-9. PubMed ID: 3085922
    [Abstract] [Full Text] [Related]

  • 6. Modulation of neuroendocrine surface antigens in oncogene-activated small cell lung cancer lines.
    Doyle LA, Mabry M, Stahel RA, Waibel R, Goldstein LH.
    Br J Cancer Suppl; 1991 Jun 07; 14():39-42. PubMed ID: 1645569
    [Abstract] [Full Text] [Related]

  • 7. Expression and amplification of myc gene family in small cell lung cancer and its relation to biological characteristics.
    Takahashi T, Obata Y, Sekido Y, Hida T, Ueda R, Watanabe H, Ariyoshi Y, Sugiura T, Takahashi T.
    Cancer Res; 1989 May 15; 49(10):2683-8. PubMed ID: 2540905
    [Abstract] [Full Text] [Related]

  • 8. Changes in the phenotype of human small cell lung cancer cell lines after transfection and expression of the c-myc proto-oncogene.
    Johnson BE, Battey J, Linnoila I, Becker KL, Makuch RW, Snider RH, Carney DN, Minna JD.
    J Clin Invest; 1986 Aug 15; 78(2):525-32. PubMed ID: 3016030
    [Abstract] [Full Text] [Related]

  • 9. A comparison of synaptophysin, chromogranin, and L-dopa decarboxylase as markers for neuroendocrine differentiation in lung cancer cell lines.
    Jensen SM, Gazdar AF, Cuttitta F, Russell EK, Linnoila RI.
    Cancer Res; 1990 Sep 15; 50(18):6068-74. PubMed ID: 2168288
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Characterization of two cell lines with distinct phenotypes established from a patient with small cell lung cancer.
    Bepler G, Jaques G, Havemann K, Koehler A, Johnson BE, Gazdar AF.
    Cancer Res; 1987 Apr 01; 47(7):1883-91. PubMed ID: 3028617
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Association of the decreased expression of alpha3beta1 integrin with the altered cell: environmental interactions and enhanced soft agar cloning ability of c-myc-overexpressing small cell lung cancer cells.
    Barr LF, Campbell SE, Bochner BS, Dang CV.
    Cancer Res; 1998 Dec 01; 58(23):5537-45. PubMed ID: 9850091
    [Abstract] [Full Text] [Related]

  • 16. Human lung cancer cell lines exhibit resistance to retinoic acid treatment.
    Geradts J, Chen JY, Russell EK, Yankaskas JR, Nieves L, Minna JD.
    Cell Growth Differ; 1993 Oct 01; 4(10):799-809. PubMed ID: 8274449
    [Abstract] [Full Text] [Related]

  • 17. Effects of c-myc oncogene modulation on differentiation of human small cell lung carcinoma cell lines.
    van Waardenburg RC, Meijer C, Pinto-Sietsma SJ, de Vries EG, Timens W, Mulder NM.
    Anticancer Res; 1998 Oct 01; 18(1A):91-5. PubMed ID: 9568061
    [Abstract] [Full Text] [Related]

  • 18. [Pathology and biology of small cell lung cancer].
    Shimosato Y.
    Gan To Kagaku Ryoho; 1988 Apr 01; 15(4 Pt 2-1):952-8. PubMed ID: 2839114
    [Abstract] [Full Text] [Related]

  • 19. Transition from SCLC to NSCLC phenotype is accompanied by an increased TRE-binding activity and recruitment of specific AP-1 proteins.
    Risse-Hackl G, Adamkiewicz J, Wimmel A, Schuermann M.
    Oncogene; 1998 Jun 11; 16(23):3057-68. PubMed ID: 9662339
    [Abstract] [Full Text] [Related]

  • 20. All-trans-retinoic acid alters myc gene expression and inhibits in vitro progression in small cell lung cancer.
    Kalemkerian GP, Jasti RK, Celano P, Nelkin BD, Mabry M.
    Cell Growth Differ; 1994 Jan 11; 5(1):55-60. PubMed ID: 8123593
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.